Publication:
Fitness for duty: social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs
Fitness for duty: social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs
dc.contributor.author | Treloar, Carla | en_US |
dc.contributor.author | Byron, Paul | en_US |
dc.contributor.author | Mccann, Pol | en_US |
dc.contributor.author | Maher, Lisa | en_US |
dc.date.accessioned | 2021-11-25T17:28:03Z | |
dc.date.available | 2021-11-25T17:28:03Z | |
dc.date.issued | 2010 | en_US |
dc.description.abstract | Several candidate vaccines for hepatitis C are currently in preclinical development or the early stages of clinical trials. Implementing trials of these vaccines among people who inject drugs will be challenging. Previous research, particularly willingness to participate studies in relation to HIV vaccines in marginalised groups, has focused on the modifiable characteristics of individual participants. This qualitative research with people who inject drugs, health staff and clinicians focuses on social, organisational and structural elements of vaccine trial designs which may exclude or reduce the participation of people who inject drugs. | en_US |
dc.identifier.issn | 18732518 | en_US |
dc.identifier.uri | http://hdl.handle.net/1959.4/50829 | |
dc.language | English | |
dc.language.iso | EN | en_US |
dc.rights | CC BY-NC-ND 3.0 | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/au/ | en_US |
dc.source | Legacy MARC | en_US |
dc.subject.other | vaccine | en_US |
dc.subject.other | hepatitis C | en_US |
dc.subject.other | clinical trial design | en_US |
dc.subject.other | social structures | en_US |
dc.subject.other | people who inject drugs | en_US |
dc.title | Fitness for duty: social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs | en_US |
dc.type | Journal Article | en |
dcterms.accessRights | metadata only access | |
dspace.entity.type | Publication | en_US |
unsw.accessRights.uri | http://purl.org/coar/access_right/c_14cb | |
unsw.identifier.doiPublisher | http://dx.doi.org/doi:10.1016/j.vaccine.2010.05.064 | en_US |
unsw.relation.faculty | Arts Design & Architecture | |
unsw.relation.faculty | Medicine & Health | |
unsw.relation.ispartofissue | 32 | en_US |
unsw.relation.ispartofjournal | Vaccine | en_US |
unsw.relation.ispartofpagefrompageto | 5228-5236 | en_US |
unsw.relation.ispartofvolume | 28 | en_US |
unsw.relation.originalPublicationAffiliation | Treloar, Carla, National Centre in HIV Social Research, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Byron, Paul, National Centre in HIV Social Research, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Mccann, Pol, National Centre in HIV Social Research, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Maher, Lisa, National Centre in HIV Epidemiology & Clinical Research, UNSW | en_US |
unsw.relation.school | Centre for Social Research in Health | * |
unsw.relation.school | The Kirby Institute | * |
unsw.subject.fieldofresearchcode | 110307 Gastroenterology and Hepatology | en_US |
unsw.subject.fieldofresearchcode | 160899 Sociology not elsewhere classified | en_US |